December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
News headline image
Rezolve Ai Warns Generic LLM Chatbots Are Embarrassing Global Brands After The Gap, Inc. Incident
From Rezolve AI Ltd
Via GlobeNewswire
Tickers RZLV
News headline image
Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
News headline image
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
News headline image
America’s Car-Mart, Inc. Completes $161.3 Million Term Securitization
From America's Car-Mart, Inc.
Via GlobeNewswire
Tickers CRMT
News headline image
Mobix Labs Reports Strong Fiscal 2025 Growth and Improved Operating Performance
From Mobix Labs, Inc.
Via GlobeNewswire
Tickers MOBX
News headline image
CGTN: How China opens its door wider with island-wide special customs operations in Hainan FTP
From CGTN
Via GlobeNewswire
News headline image
Sezzle’s MoneyIQ Reaches One Million Lessons in Its First Year
From Sezzle
Via GlobeNewswire
Tickers SEZL
News headline image
DMG Blockchain Solutions Reports Fourth Quarter and Full Year 2025 Audited Results
From DMG Blockchain Solutions Inc.
Via GlobeNewswire
Tickers DMGGF TSX-V:DMGI
News headline image
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
From ProMIS Neurosciences Inc.
Via GlobeNewswire
Tickers PMN
News headline image
K Wave Media Issues Corporate Update Highlighting SEC Clearance, Strategic Acquisition, and Financial Restructuring Progress
From K Wave Media
Via GlobeNewswire
Tickers KWM
News headline image
FuelCell Energy Ends FY2025 with Revenue Growth and a Focus on Data Center Opportunities
From FuelCell Energy, Inc.
Via GlobeNewswire
Tickers FCEL
News headline image
Terra Innovatum Global Honored with Sustainability Special Mention at 2025 UNCA Awards
From Terra Innovatum Global N.V
Via GlobeNewswire
Tickers NKLR
News headline image
Regenx Receives Funding Support to Advance Proprietary Technology
From Regenx Tech Corp.
Via GlobeNewswire
Tickers CSE:RGX RGXTF
News headline image
Yacht Club de Monaco closes the 2025 season with the YCM Awards
From Yacht Club de Monaco
Via GlobeNewswire
News headline image
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
From CAMP4 Therapeutics
Via GlobeNewswire
Tickers CAMP
News headline image
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
From Athira Pharma, Inc.
Via GlobeNewswire
Tickers ATHA
News headline image
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination
From Sagimet Biosciences Inc.
Via GlobeNewswire
Tickers SGMT
News headline image
Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets
From Hydreight Technologies Inc.
Via GlobeNewswire
Tickers CSE:VST HYDTF TSX-V:NURS VSQTF
News headline image
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
News headline image
ONAR Holding Corporation Retires $311,000 in Debt Through Equity Conversion, Strengthens Balance Sheet, and Aligns Long-Term Partners with Shareholders
From ONAR Holding Corporation
Via GlobeNewswire
Tickers ONAR
News headline image
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
From Nutriband Inc.
Via GlobeNewswire
Tickers NTRB NTRBW
News headline image
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Perspective Therapeutics, Inc.
Via GlobeNewswire
News headline image
OTC Markets Group Welcomes Quartz Mountain Resources Ltd. to OTCQX
From OTC Markets
Via GlobeNewswire
Tickers OTCM QZMRF TSX-V:QZM
News headline image
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
From Pyxis Oncology
Via GlobeNewswire
Tickers PYXS
News headline image
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
From Gain Therapeutics, Inc.
Via GlobeNewswire
Tickers GANX
News headline image
Talisker Provides Update on Staff Reduction at Bralorne due to Atmospheric River Event in Southern British Columbia
From Talisker Resources Ltd.
Via GlobeNewswire
Tickers TSKFF TSX:TSK TSX:TSK-WT
News headline image
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
From CAMP4 Therapeutics
Via GlobeNewswire
Tickers CAMP
News headline image
RentRedi Announces Winners of First Annual “Be Property Wise” Awards, Honoring Smart, Modern Landlords Across the U.S.
From RentRedi
Via GlobeNewswire
News headline image
Trump Media & Technology Group to Merge with TAE Technologies, a Premier Fusion Power Company, in All-Stock Transaction Valued at More Than $6 Billion
From Trump Media & Technology Group; TAE Technologies, Inc.
Via GlobeNewswire
Tickers DJT
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.